Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment

BACKGROUND: The major obstacle impeding human immunodeficiency virus-1 (HIV-1) eradication in antiretroviral treatment (ART) treated HIV-1 subjects is the establishment of long-lived latently infected resting CD4(+) T cells. Due to the fact that no drug has been effective, the search for new drugs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Relaño-Rodríguez, Ignacio, Juárez-Sánchez, Raquel, Pavicic, Carolina, Muñoz, Eduardo, Muñoz-Fernández, Maria Ángeles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529996/
https://www.ncbi.nlm.nih.gov/pubmed/31113488
http://dx.doi.org/10.1186/s12951-019-0500-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529996/
https://www.ncbi.nlm.nih.gov/pubmed/31113488
http://dx.doi.org/10.1186/s12951-019-0500-4

Ejemplares similares